Conferences are an essential communication channel for pharmaceutical companies. But how can marketeers be confident their marketing budgets are not wasted?
Marketing Mix Modeling (MMM) is a method for all industries, and especially for pharmaceuticals. It supports companies in several important ways. First, MMM helps identify the baseline: the portion of sales that would have occurred without any marketing activity. The baseline is primarily driven by brand strength and the existing network the pharmaceutical company has already established. Second, MMM quantifies the incremental impact of each marketing activity. For example, it can show how much revenue conferences in specific therapeutic areas generated during a given period.
Beyond measuring current performance, MMM also enables better decision-making. It provides deep insights into marketing effectiveness, including ROI, cost per incremental acquisition, and channel efficiency, all of which support smarter budget allocation. One of MMM’s most powerful features is its ability to identify the point of diminishing returns, helping companies understand when additional investment in a channel no longer generates proportional value.
MMM is essential for pharmaceuticals particularly for those that rely heavily on conferences as a key marketing channel
Conferences often represent a significant expense for pharmaceutical companies. They must be planned well in advance, with budgets carefully allocated, attendance secured, and content tailored to provide real value for participants. Organizing a conference or symposium can therefore involve substantial costs, making it critical for companies to ensure that these investments deliver measurable impact.
The effectiveness of a conference is always questionable.
As a result, the commercial value of a conference is not easily defined by marketing or finance teams. Pharmaceutical companies often struggle to justify or secure budgets for such events, while larger organizations with greater resources dominate the space and host the majority of high-profile conferences and symposia.
In the pharmaceutical industry, conferences can generally be grouped into two types: scientific/educational events and promotional/marketing events.
Scientific / Educational Events
Examples include medical congresses, CME events, investigator meetings, advisory boards, and patient advocacy or awareness events. The primary purpose of these gatherings is to share knowledge, exchange scientific information, educate healthcare professionals or patients, and gather expert insights. To ensure compliance, the content presented must be non-promotional and evidence-based, with no discussion of off-label uses. In the case of CME, content must remain fully independent from sponsor influence. Hospitality may be offered but only if it is reasonable, modest, and strictly secondary to the scientific or educational objectives of the event.
Promotional / Marketing Events
Examples include company-sponsored symposia, promotional booths at congresses, product launch events, and sales representative meetings with healthcare professionals. The purpose of these activities is to present product benefits, raise awareness among HCPs, and drive prescriptions within the boundaries of legal and ethical regulations. Such events must only be directed at HCPs and never at the general public. All promotional materials require prior approval and must be accurate, balanced, and fully compliant with regulatory standards. Strict controls apply to gifts, hospitality, and expenses, and every communication must include mandatory safety information and clear disclosures.
Although pharmaceutical companies may pursue different approaches to achieve their objectives, the cost of conferences can vary significantly depending on the type. Nevertheless, assessing the efficiency and true commercial value of each event remains a challenge.
A comprehensive way to evaluate the impact of conferences is through Marketing Mix Modeling (MMM). When supplied with the right data, MMM can deliver precise insights into the effectiveness of these activities, helping companies move beyond assumptions to measurable outcomes.
In the example above, we see that the pharmaceutical’s baseline is 37%, which translates to 13.3 million of the business KPI, while conferences contributed a combined 0.3 million during the same period.
Marketing Mix Modeling can also provide deeper insights into the messaging communicated at conferences. For instance, it can help determine whether Messaging A outperformed Messaging B across different events, allowing the pharmaceutical to refine its strategy not only for conferences but also across all therapeutic areas.
Reach out to us at info@mar-sci.com to learn how we your business improve your sales and marketing effectiveness.